pubmed-article:556715 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:556715 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
pubmed-article:556715 | lifeskim:mentions | umls-concept:C2698297 | lld:lifeskim |
pubmed-article:556715 | lifeskim:mentions | umls-concept:C0018923 | lld:lifeskim |
pubmed-article:556715 | lifeskim:mentions | umls-concept:C1527148 | lld:lifeskim |
pubmed-article:556715 | lifeskim:mentions | umls-concept:C0046329 | lld:lifeskim |
pubmed-article:556715 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:556715 | pubmed:dateCreated | 1977-3-15 | lld:pubmed |
pubmed-article:556715 | pubmed:abstractText | Subcutaneous hemangiosarcomas developed in 97% of 172 B6C3F1 mice of both sexes fed either 0.03% or 0.36% 2-methyl-1-nitroanthraquinone in the diet. There was no significant relationship to dose or sex. In addition similar vascular tumors occurred in the mesentery of 14 mice. 2-Methyl-1-nitroanthraquinone is carcinogenic in B6C3F1 mice when given in food. One of 97 control mice had a splenic hemangiosarcoma. | lld:pubmed |
pubmed-article:556715 | pubmed:language | eng | lld:pubmed |
pubmed-article:556715 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:556715 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:556715 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:556715 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:556715 | pubmed:month | Jan | lld:pubmed |
pubmed-article:556715 | pubmed:issn | 0020-7136 | lld:pubmed |
pubmed-article:556715 | pubmed:author | pubmed-author:SmithE RER | lld:pubmed |
pubmed-article:556715 | pubmed:author | pubmed-author:BakerJ RJR | lld:pubmed |
pubmed-article:556715 | pubmed:author | pubmed-author:WebbJ AJA | lld:pubmed |
pubmed-article:556715 | pubmed:author | pubmed-author:Krishna... | lld:pubmed |
pubmed-article:556715 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:556715 | pubmed:volume | 19 | lld:pubmed |
pubmed-article:556715 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:556715 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:556715 | pubmed:pagination | 117-21 | lld:pubmed |
pubmed-article:556715 | pubmed:dateRevised | 2007-7-24 | lld:pubmed |
pubmed-article:556715 | pubmed:meshHeading | pubmed-meshheading:556715-A... | lld:pubmed |
pubmed-article:556715 | pubmed:meshHeading | pubmed-meshheading:556715-M... | lld:pubmed |
pubmed-article:556715 | pubmed:meshHeading | pubmed-meshheading:556715-S... | lld:pubmed |
pubmed-article:556715 | pubmed:meshHeading | pubmed-meshheading:556715-M... | lld:pubmed |
pubmed-article:556715 | pubmed:meshHeading | pubmed-meshheading:556715-A... | lld:pubmed |
pubmed-article:556715 | pubmed:meshHeading | pubmed-meshheading:556715-L... | lld:pubmed |
pubmed-article:556715 | pubmed:meshHeading | pubmed-meshheading:556715-M... | lld:pubmed |
pubmed-article:556715 | pubmed:meshHeading | pubmed-meshheading:556715-F... | lld:pubmed |
pubmed-article:556715 | pubmed:meshHeading | pubmed-meshheading:556715-M... | lld:pubmed |
pubmed-article:556715 | pubmed:meshHeading | pubmed-meshheading:556715-H... | lld:pubmed |
pubmed-article:556715 | pubmed:meshHeading | pubmed-meshheading:556715-N... | lld:pubmed |
pubmed-article:556715 | pubmed:meshHeading | pubmed-meshheading:556715-M... | lld:pubmed |
pubmed-article:556715 | pubmed:meshHeading | pubmed-meshheading:556715-D... | lld:pubmed |
pubmed-article:556715 | pubmed:year | 1977 | lld:pubmed |
pubmed-article:556715 | pubmed:articleTitle | Development of hemangiosarcomas in B6C3F1 mice fed 2-methyl-1-nitroanthraquinone. | lld:pubmed |
pubmed-article:556715 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:556715 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:556715 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:556715 | lld:pubmed |